A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan
NCT ID: NCT05228158
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
145 participants
OBSERVATIONAL
2021-08-16
2028-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma
NCT07209163
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies
NCT07282548
Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
NCT00568815
Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy
NCT02889523
To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL)
NCT04661007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tazemetostat
Participants with relapsed or refractory follicular lymphoma with EZH2 gene mutation will receive Tazemetostat 800 milligram (mg), tablet, orally, twice daily or as per physicians discretion in routine clinical practice. All the participants will be observed for up to Week 52 prospectively.
Tazemetostat
Tazemetostat oral tablets.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tazemetostat
Tazemetostat oral tablets.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Participants treated with tazemetostat
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eisai Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eisai Trial Site 131
Komaki-shi, Aichi-ken, Japan
Eisai Trial Site 199
Konan-shi, Aichi-ken, Japan
Eisai Trial Site 21
Nagakute-shi, Aichi-ken, Japan
Eisai Trial Site 106
Nagoya, Aichi-ken, Japan
Eisai Trial Site 156
Nagoya, Aichi-ken, Japan
Eisai Trial Site 174
Nagoya, Aichi-ken, Japan
Eisai Trial Site 91
Nagoya, Aichi-ken, Japan
Eisai Trial Site 170
Okazaki-shi, Aichi-ken, Japan
Eisai Trial Site 181
Seto-shi, Aichi-ken, Japan
Eisai Trial Site 130
Toyohashi, Aichi-ken, Japan
Eisai Trial Site 226
Toyokawa-shi, Aichi-ken, Japan
Eisai Trial Site 133
Toyota-shi, Aichi-ken, Japan
Eisai Trial Site 205
Yatomi-shi, Aichi-ken, Japan
Eisai Trial Site 240
Akita, Akita, Japan
Eisai Trial Site 234
Hirosaki-shi, Aomori, Japan
Eisai Trial Site 96
Hirosaki-shi, Aomori, Japan
Eisai Trial Site 119
Chiba, Chiba, Japan
Eisai Trial Site 5
Kashiwa-shi, Chiba, Japan
Eisai Trial Site 195
Matsudo-shi, Chiba, Japan
Eisai Trial Site 25
Matsuyama, Ehime, Japan
Eisai Trial Site 176
Fukuoka, Fukuoka, Japan
Eisai Trial Site 227
Fukuoka, Fukuoka, Japan
Eisai Trial Site 46
Fukuoka, Fukuoka, Japan
Eisai Trial Site 134
Iizuka-shi, Fukuoka, Japan
Eisai Trial Site 230
Kitakyusyu-shi, Fukuoka, Japan
Eisai Trial Site 252
Aizuwakayam-shi, Fukushima, Japan
Eisai Trial Site 82
Iwaki, Fukushima, Japan
Eisai Trial Site 244
Koriyama-shi, Fukushima, Japan
Eisai Trial Site 125
Ogaki-shi, Gifi, Japan
Eisai Trial Site 27
Gifu, Gifu, Japan
Eisai Trial Site 28
Gifu, Gifu, Japan
Eisai Trial Site 45
Fujioka-shi, Gunma, Japan
Eisai Trial Site 224
Maebashi, Gunma, Japan
Eisai Trial Site 235
Tatebayashi-shi, Gunma, Japan
Eisai Trial Site 57
Fukuyama-shi, Hiroshima, Japan
Eisai Trial Site 52
Hiroshima, Hiroshima, Japan
Eisai Trial Site 222
Asahikawa-shi, Hokkaido, Japan
Eisai Trial Site 198
Kitami-shi, Hokkaido, Japan
Eisai Trial Site 71
Kushiro, Hokkaido, Japan
Eisai Trial Site 167
Sapporo, Hokkaido, Japan
Eisai Trial Site 183
Sapporo, Hokkaido, Japan
Eisai Trial Site 212
Akashi-shi, Hyōgo, Japan
Eisai Trial Site 72
Akashi-shi, Hyōgo, Japan
Eisai Trial Site 31
Amagasaki-shi, Hyōgo, Japan
Eisai Trial Site 124
Itami-shi, Hyōgo, Japan
Eisai Trial Site 238
Kobe, Hyōgo, Japan
Eisai Trial Site 89
Kobe, Hyōgo, Japan
Eisai Trial Site 93
Kobe, Hyōgo, Japan
Eisai Trial Site 44
Nishinomiya-shi, Hyōgo, Japan
Eisai Trial Site 29
Hitachi-shi, Ibaraki, Japan
Eisai Trial Site 237
Toride-shi, Ibaraki, Japan
Eisai Trial Site 105
Takamatsu, Kagawa-ken, Japan
Eisai Trial Site 118
Kagoshima, Kagoshima-ken, Japan
Eisai Trial Site 207
Kanoya-shi, Kagoshima-ken, Japan
Eisai Trial Site 109
Ebina-shi, Kanagawa, Japan
Eisai Trial Site 17
Kawasaki-shi, Kanagawa, Japan
Eisai Trial Site 190
Kawasaki-shi, Kanagawa, Japan
Eisai Trial Site 87
Sagamihara-shi, Kanagawa, Japan
Eisai Trial Site 177
Yokohama, Kanagawa, Japan
Eisai Trial Site 43
Yokohama, Kanagawa, Japan
Eisai Trial Site 169
Yokosuka-shi, Kanagawa, Japan
Eisai Trial Site 9
Nankoku-shi, Kochi, Japan
Eisai Trial Site 253
Kumamoto, Kumamoto, Japan
Eisai Trial Site 55
Kumamoto, Kumamoto, Japan
Eisai Trial Site 26
Kyoto, Kyoto, Japan
Eisai Trial Site 4
Kyoto, Kyoto, Japan
Eisai Trial Site 56
Kyoto, Kyoto, Japan
Eisai Trial Site 76
Kyoto, Kyoto, Japan
Eisai Trial Site 122
Matsusaka-shi, Mie-ken, Japan
Eisai Trial Site 36
Matsusaka-shi, Mie-ken, Japan
Eisai Trial Site 186
Yokkaichi-shi, Mie-ken, Japan
Eisai Trial Site 242
Osaki-shi, Miyagi, Japan
Eisai Trial Site 161
Sendai, Miyagi, Japan
Eisai Trial Site 189
Nobeoka-shi, Miyazaki, Japan
Eisai Trial Site 192
Matsumoto-shi, Nagano, Japan
Eisai Trial Site 208
Matsumoto-shi, Nagano, Japan
Eisai Trial Site 127
Nagasaki, Nagasaki, Japan
Eisai Trial Site 251
Kashihara-shi, Nara, Japan
Eisai Trial Site 2
Maniwa-shi, Okayama-ken, Japan
Eisai Trial Site 12
Okayama, Okayama-ken, Japan
Eisai Trial Site 14
Okayama, Okayama-ken, Japan
Eisai Trial Site 178
Okayama, Okayama-ken, Japan
Eisai Trial Site 41
Okayama, Okayama-ken, Japan
Eisai Trial Site 18
Nakagami-gun, Okinawa, Japan
Eisai Trial Site 204
Okinawa-shi, Okinawa, Japan
Eisai Trial Site 164
Hirakata-shi, Osaka, Japan
Eisai Trial Site 49
Izumisano, Osaka, Japan
Eisai Trial Site 239
Kawachinagano-shi, Osaka, Japan
Eisai Trial Site 59
Kawachinagano-shi, Osaka, Japan
Eisai Trial Site 144
Osaka, Osaka, Japan
Eisai Trial Site 165
Osaka, Osaka, Japan
Eisai Trial Site 179
Osaka, Osaka, Japan
Eisai Trial Site 213
Osaka, Osaka, Japan
Eisai Trial Site 220
Osaka, Osaka, Japan
Eisai Trial Site 228
Osaka, Osaka, Japan
Eisai Trial Site 60
Osaka, Osaka, Japan
Eisai Trial Site 221
Sakai-shi, Osaka, Japan
Eisai Trial Site 233
Takatsuki-shi, Osaka, Japan
Eisai Trial Site 98
Toyonaka-shi, Osaka, Japan
Eisai Trial Site 247
Saga, Saga-ken, Japan
Eisai Trial Site 254
Ageo-shi, Saitama, Japan
Eisai Trial Site 148
Hidaka-shi, Saitama, Japan
Eisai Trial Site 152
Saitama-shi, Saitama, Japan
Eisai Trial Site 197
Saitama-shi, Saitama, Japan
Eisai Trial Site 140
Tokorozawa-shi, Saitama, Japan
Eisai Trial Site 175
Ōtsu, Shiga, Japan
Eisai Trial Site 223
Iwata-shi, Shizuoka, Japan
Eisai Trial Site 40
Izunokuni-shi, Shizuoka, Japan
Eisai Trial Site 88
Shizuoka, Shizuoka, Japan
Eisai Trial Site 201
Shimotsuke-shi, Tochigi, Japan
Eisai Trial Site 245
Shimotsuke-shi, Tochigi, Japan
Eisai Trial Site 243
Komatsushima-shi, Tokushima, Japan
Eisai Trial Site 101
Tokushima, Tokushima, Japan
Eisai Trial Site 187
Tokushima, Tokushima, Japan
Eisai Trial Site 158
Bunkyo-ku, Tokyo, Japan
Eisai Trial Site 193
Bunkyo-ku, Tokyo, Japan
Eisai Trial Site 225
Chiyoda-ku, Tokyo, Japan
Eisai Trial Site 241
Chofu-shi, Tokyo, Japan
Eisai Trial Site 1
Chuo-ku, Tokyo, Japan
Eisai Trial Site 107
Edogawa-ku, Tokyo, Japan
Eisai Trial Site 249
Kita-ku, Tokyo, Japan
Eisai Trial Site 229
Meguro-ku, Tokyo, Japan
Eisai Trial Site 50
Minato-ku, Tokyo, Japan
Eisai Trial Site 24
Shinagawa-Ku, Tokyo, Japan
Eisai Trial Site 162
Shinjuku-ku, Tokyo, Japan
Eisai Trial Site 248
Shinjuku-ku, Tokyo, Japan
Eisai Trial Site 159
Suginami-ku, Tokyo, Japan
Eisai Trial Site 231
Taito-ku, Tokyo, Japan
Eisai Trial Site 202
Toshima-ku, Tokyo, Japan
Eisai Trial Site 83
Yonago-shi, Tottori, Japan
Eisai Trial Site 188
Toyama, Toyama, Japan
Eisai Trial Site 246
Toyama, Toyama, Japan
Eisai Trial Site 142
Tanabe-shi, Wakayama, Japan
Eisai Trial Site 236
Wakayama, Wakayama, Japan
Eisai Trial Site 20
Sakata-shi, Yamagata, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E7438-M081-501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.